Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:47:43 GMT 2023
by
admin
on
Sat Dec 16 11:47:43 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
68L32FM3IQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
P10828
Created by
admin on Sat Dec 16 11:47:43 GMT 2023 , Edited by admin on Sat Dec 16 11:47:43 GMT 2023
|
PRIMARY | |||
|
68L32FM3IQ
Created by
admin on Sat Dec 16 11:47:43 GMT 2023 , Edited by admin on Sat Dec 16 11:47:43 GMT 2023
|
PRIMARY | |||
|
P10828
Created by
admin on Sat Dec 16 11:47:43 GMT 2023 , Edited by admin on Sat Dec 16 11:47:43 GMT 2023
|
PRIMARY |
Linkage Type | Residue Index | |
---|---|---|
ZINC FINGER | 1_107 | 1_127 |
ZINC FINGER | 1_145 | 1_169 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
AGONIST -> TARGET |
Binds selectively to the main hepatic form of thyroid hormone (TH) receptor, TRβ1, compared to TRα1, which is principally responsible for thyrotoxic effects on heart, muscle and bone.
|
||
|
AGONIST -> TARGET |
increased expression of the hepatic LDL-receptor gene
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
28 times more selective to TR.beta. than TR.alpha.
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
MIMETIC->TARGET | |||
|
AGONIST -> TARGET |
Increased ABCD2 gene expression by 10-fold in X-ALD fibroblasts (4 nm)
EC50
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT | CHEMICAL |
|